We earn commissions from brands listed on this site, which influences how listings are presented.
Science-backed medications. Trusted telehealth providers. Real results.
Access GLP-1 treatments like semaglutide and tirzepatide, including Wegovy®, Ozempic®, and Mounjaro®, for effective weight management — all from the comfort of your home.
Medically Reviewed by
Licensed Healthcare Professionals
Advertising Disclosure: We earn commissions from brands featured on this site. This may affect listing placement but does not influence our editorial ratings, which are based on independent research. All GLP-1 medications require a prescription from a licensed provider.
Transparency matters. Here's how our editorial process works.
Our team evaluates each provider based on available medications, pricing, clinical support quality, user experience, and clinical evidence.
We assign scores on a 10-point scale based on medication access, cost transparency, provider credentials, customer support, and user reviews.
Listings are reviewed and updated monthly to reflect new pricing, medication availability, promotions, and provider changes.
We receive compensation from featured providers through affiliate partnerships. This helps keep our site free for users but may influence listing placement and order.
Affiliate Disclosure: GLP-1 Guide is an independently operated comparison website. We may receive referral compensation from the providers featured on this site when you click a link or complete an action (such as filling out a form). This compensation may influence which providers appear on this page, the order in which they appear, and the ratings and scores we assign. However, our editorial opinions are our own and are not influenced by compensation. We do not include every provider on the market. All content is for informational purposes only and should not be considered medical advice.
GLP-1 receptor agonists are a breakthrough class of medications reshaping how we approach weight management and metabolic health.
GLP-1 (Glucagon-Like Peptide-1) is a naturally occurring hormone your body produces after eating. It plays a key role in regulating appetite, blood sugar, and digestion.
GLP-1 receptor agonist medications mimic this hormone at higher levels, producing stronger and more sustained effects on appetite control and metabolic function.
Reduces hunger cues so you feel satisfied with less food.
Food stays in your stomach longer, keeping you fuller between meals.
Helps your body better manage blood sugar after eating.
Lowers the amount of sugar your liver releases into the bloodstream.
15–22% body weight reduction in clinical studies over ~68 weeks.
Studies show reduced risk of cardiovascular events in some patients.
Improved A1C levels and better insulin sensitivity.
Reduced cravings and feeling satisfied with smaller portions.
A comprehensive overview of GLP-1 receptor agonists available for weight loss and type 2 diabetes management.
| Brand Name | Active Ingredient | Type | Primary Use | Dosing | FDA Status |
|---|---|---|---|---|---|
| Wegovy® | Semaglutide (injectable) | Weekly Injection | Weight Loss | Once weekly | Approved for obesity |
| Wegovy® | Semaglutide (oral) | Daily Tablet | Weight Loss | Once daily | Approved for obesity |
| Ozempic® | Semaglutide (injectable) | Weekly Injection | Type 2 Diabetes | Once weekly | Approved for type 2 diabetes |
| Rybelsus® | Semaglutide (oral) | Daily Tablet | Type 2 Diabetes | Once daily | Approved for type 2 diabetes |
| Saxenda® | Liraglutide | Daily Injection | Weight Loss | Once daily | Approved for obesity |
| Victoza® | Liraglutide | Daily Injection | Type 2 Diabetes | Once daily | Approved for type 2 diabetes |
| Mounjaro® | Tirzepatide (GLP-1 + GIP) | Weekly Injection | Type 2 Diabetes | Once weekly | Approved for type 2 diabetes* |
| Zepbound® | Tirzepatide (GLP-1 + GIP) | Weekly Injection | Weight Loss | Once weekly | Approved for obesity |
* Mounjaro® is FDA-approved for type 2 diabetes. Weight loss use is considered off-label. Always consult your healthcare provider for guidance on the appropriate medication for your needs.
Compounded GLP-1 treatments contain the same active ingredients as branded medications, but are custom-prepared by licensed compounding pharmacies and are not FDA-approved as finished products.
FDA-approved: Rigorously tested for safety and efficacy. Manufactured under strict quality controls.
Compounded: May be prescribed during shortages or for custom dosing. Quality can vary by pharmacy.
Appetite changes and reduced cravings begin as your body adjusts to the medication.
Noticeable weight loss as dosage is gradually increased to therapeutic levels.
Studies show 15–22% body weight reduction when combined with lifestyle changes.
Ongoing treatment is typically needed to maintain results. Your provider will guide you.
Answers to common questions about GLP-1 weight loss treatments.
Compare trusted GLP-1 providers, understand your options, and take the first step toward clinically proven weight management.